Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Working with researchers from America’s top institutions, Dr. Peter Kowey is senior author of a study assessing treatment for a condition linked to high stroke risk

News | Atrial Fibrillation

Ablation is Safe and Effective in Treating Atrial Fibrillation, Research Guided by Main Line Health Expert Shows

April 6, 2023 — Atrial fibrillation (AFib) not only causes shortness of breath and palpitations but puts patients at ...

April 06, 2023

Part-time degree format will provide vital skills for career advancement in cardiac device interventional technologies

News | Cardiovascular Education

Harding University Introduces New Professional Pathway Tailored to Cardiac Professionals for its Master of Science in Cardiac Function and Interventional Technology

April 4, 2023 — Harding University has announced it will offer a new degree format for its Master of Science in cardiac ...

April 04, 2023

North America to account for larger share in atrial fibrillation market during 2022–2028; growth driven by rising geriatric population, increasing occurrence of cardiovascular diseases, high accessibility to advanced technologies, growing development of innovative and technologically advanced products, and increasing healthcare expenditure

Feature | Atrial Fibrillation

Atrial Fibrillation Market Reaches $20.92B, According to New Report

According to our latest study on "Atrial Fibrillation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by ...

April 04, 2023

The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood pressure in youth were outlined in a new scientific statement from the American Heart Association, published March 30 in the Association’s Hypertension journal.

News | Hypertension

Children with High Blood Pressure in Spotlight with AHA Journal Scientific Statement

April 4, 2023 — The need for appropriate diagnosis, treatment and reduction of lifestyle risk factors for high blood ...

April 04, 2023

Results demonstrate significant reductions in LDL-C, hsCRP and cardiovascular risk in patients who are unable to maximize or tolerate a statin

News | Pharmaceuticals

Landmark CLEAR Outcomes Study Demonstrates NEXLETOL (bempedoic acid) Tablet is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad Population

April 3, 2023 — Esperion announced the full results from the landmark Cholesterol Lowering via Bempedoic acid, an ACL ...

April 03, 2023

Clearance of the IND will pave the way for the Company to initiate its randomized controlled Phase 1/2a MOJAVE study in the US, planned for Q2 2023

News | Pharmaceuticals

Sequana Medical Announces Submission of Investigational New Drug (IND) Application for DSR 2.0 for Treatment of Congestive Heart Failure

April 3, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

April 03, 2023

Here's a look at what viewers found most interesting during the month of March

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: What Viewers were reading in March

In the blink of an eye yet another month has passed, and here is a look at the Top 10 of what DIcardiology.com viewers ...

April 03, 2023

According to a new release issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary of Getinge, is recalling Cardiosave Hybrid IABPs and Rescue IABPs because a communication loss between the executive processor printed circuit board assembly (PCBA) and the video generator PCBA may cause an unexpected shutdown

News | Intra-Aortic Balloon Pumps (IABP)

Datascope/Getinge Issues New Recall of Certain Cardiosave Hybrid and Rescue IABPs for Risk of Unexpected Shutdown

March 31, 2023 — According to statement issued by the U.S. Food and Drug Administration (FDA), Datascope, a subsidiary ...

March 31, 2023

The new valve is designed to preserve and facilitate future patient options for lifetime management of their heart valve disease

News | Structural Heart

Abbott Receives FDA Approval for Epic Max Tissue Valve to Treat Aortic Valve Disease

March 31, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's Epic Max ...

March 31, 2023

New data shows steep increase of usually fatal heart condition during pandemic, with 38% increase for all county residents and 77% increase for Hispanic residents

News | Sudden Cardiac Arrest

Risk of Sudden Cardiac Arrest Rises Sharply in Ventura County

March 31, 2023 — In a study among residents of Ventura County, Calif., rates of sudden cardiac arrest rose sharply ...

March 31, 2023

The hub contains original content from five conferences including ACC’s 2022 and 2023 Annual Scientific Session, with additional conferences to be added in the future

News | Cardiovascular Education

Evermed, ACC Launch ACC Anywhere, the 'Netflix of Cardiology'

March 30, 2023 — Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new ...

March 30, 2023

The breakthrough findings solve a known problem for scientists working on cellular reprogramming, one of the most promising areas of regenerative medicine

News | Heart Failure

Heart Attack Study Could Change the Game in Regenerative Medicine

March 30, 2023 — Sanford Burnham Prebys researchers have identified a group of proteins that could be the secret to ...

March 30, 2023

Growth-focused leader will help bring the company’s AI-powered cardiovascular technology to market

News | Cardiovascular Business

Andrew Miller Joins Elucid as Chief Technology Officer

March 29, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

March 29, 2023

More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men

News | Womens Cardiovascular Health

Women are More Likely to Experience Long-term Anxiety After Cardiac Arrest than Men

March 29, 2023 — More than 40% of women report anxiety four months after a cardiac arrest compared with 23% of men ...

March 29, 2023

A joint team of researchers from POSTECH and Georgia Institute of Technology successfully created an engineered heart via 3D printing technology that allows for early monitoring of drug-induced cardiotoxicity

News | Medical 3-D Printing

In Vitro 3D Engineered Heart Tissue that Monitors Drug-induced Cardiotoxicity

March 29, 2023 — Cardiotoxicity is a clinical condition that arises from using pharmaceutical agents such as antibiotics ...

March 29, 2023